Detalhe da pesquisa
1.
Targeting myeloid chemotaxis to reverse prostate cancer therapy resistance.
Nature
; 623(7989): 1053-1061, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37844613
2.
Development and Validation of a New BAG-1L-Specific Antibody to Quantify BAG-1L Protein Expression in Advanced Prostate Cancer.
Lab Invest
; 103(11): 100245, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37652207
3.
Association of Serum Carotenoids and Retinoids with Intraprostatic Inflammation in Men without Prostate Cancer or Clinical Indication for Biopsy in the Placebo Arm of the Prostate Cancer Prevention Trial.
Nutr Cancer
; 74(1): 141-148, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-33511883
4.
Olaparib in patients with metastatic castration-resistant prostate cancer with DNA repair gene aberrations (TOPARP-B): a multicentre, open-label, randomised, phase 2 trial.
Lancet Oncol
; 21(1): 162-174, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31806540
5.
The association between serum sex steroid hormone concentrations and intraprostatic inflammation in men without prostate cancer and irrespective of clinical indication for biopsy in the placebo arm of the Prostate Cancer Prevention Trial.
Prostate
; 80(11): 895-905, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32506665
6.
Molecular evidence that invasive adenocarcinoma can mimic prostatic intraepithelial neoplasia (PIN) and intraductal carcinoma through retrograde glandular colonization.
J Pathol
; 238(1): 31-41, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26331372
7.
Key genes involved in the immune response are generally not associated with intraprostatic inflammation in men without a prostate cancer diagnosis: Results from the prostate cancer prevention trial.
Prostate
; 76(6): 565-74, 2016 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-26771888
8.
PTEN loss and chromosome 8 alterations in Gleason grade 3 prostate cancer cores predicts the presence of un-sampled grade 4 tumor: implications for active surveillance.
Mod Pathol
; 29(7): 764-71, 2016 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-27080984
9.
Secreted protein, acidic and rich in cysteine-like 1 (SPARCL1) is down regulated in aggressive prostate cancers and is prognostic for poor clinical outcome.
Proc Natl Acad Sci U S A
; 109(37): 14977-82, 2012 Sep 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-22927397
10.
Effects of Ginkgo biloba extract on spinal cord ischemia-reperfusion injury in rats.
Ann Vasc Surg
; 28(5): 1296-305, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24561208
11.
CB307: A Dual Targeting Costimulatory Humabody VH Therapeutic for Treating PSMA-Positive Tumors.
Clin Cancer Res
; 30(8): 1595-1606, 2024 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38593226
12.
Capivasertib in combination with enzalutamide for metastatic castration resistant prostate cancer after docetaxel and abiraterone: Results from the randomized phase II RE-AKT trial.
Eur J Cancer
; 205: 114103, 2024 May 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38729054
13.
Thio-2 inhibits key signaling pathways required for the development and progression of castration resistant prostate cancer.
Mol Cancer Ther
; 2024 Feb 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-38412481
14.
Global levels of H3K27me3 track with differentiation in vivo and are deregulated by MYC in prostate cancer.
Am J Pathol
; 181(2): 560-9, 2012 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-22713676
15.
Unbiased differential proteomic profiling between cancer-associated fibroblasts and cancer cell lines.
J Proteomics
; 288: 104973, 2023 09 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-37481068
16.
Germline ATM Mutations Detected by Somatic DNA Sequencing in Lethal Prostate Cancer.
Eur Urol Open Sci
; 52: 72-78, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-37284046
17.
Olaparib and Ceralasertib (AZD6738) in Patients with Triple-Negative Advanced Breast Cancer: Results from Cohort E of the plasmaMATCH Trial (CRUK/15/010).
Clin Cancer Res
; 29(23): 4751-4759, 2023 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37773077
18.
Apolipoprotein E induces pathogenic senescent-like myeloid cells in prostate cancer.
Cancer Cell
; 41(3): 602-619.e11, 2023 03 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-36868226
19.
B7-H3 as a Therapeutic Target in Advanced Prostate Cancer.
Eur Urol
; 83(3): 224-238, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36114082
20.
An immunohistochemical signature comprising PTEN, MYC, and Ki67 predicts progression in prostate cancer patients receiving adjuvant docetaxel after prostatectomy.
Cancer
; 118(24): 6063-71, 2012 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-22674438